Role of serum amyloid a as a biomarker for predicting the severity and prognosis of covid-19

HIGHLIGHTS

• who: Amal A. Abbas and collaborators from the Laboratory Department, King Fahd General Hospital, MOH, Jeddah, Saudi Arabia Clinical Pathology Department, Faculty of Medicine, Ain Shams University, Egypt have published the research work: Role of Serum Amyloid A as a Biomarker for Predicting the Severity and Prognosis of COVID-19, in the Journal: Journal of Immunology Research of 24/Nov/2022
• what: The study findings indicate that SAA can be used as a sensitive indicator to assess the degree of disease severity and survival outcomes of COVID-19 patients. Prior to the initiation of the . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.